Outcome Measurement Flashcards

1
Q

It is the result, effect or product, usually of some action. In the context of health, it is the effect on the patient’s health status that is attributed to an intervention.

A

Outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Specific result or effect that can be measured.

A

Outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Example/s of Outcomes in the Context of Health

A

• Decreases Pain
• Reduce Tumor Size
• Body Temperature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The end results of medical care. What happened to the patient in terms of palliation, control of illness, cure, or rehabilitation.

A

Outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

It directs the attention specifically to the patient’s well-being; it emphasizes individuals over groups, and the interests of unique patients over those of society.

A

Outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

It can be measured clinically.

A

Outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Example/s of Outcomes (Clinically)

A

• Physical Examinations
• Laboratory Tests
• Imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

(T/F): The outcomes used in economic evaluations should ideally reflect final health outcomes rather than intermediate clinical markers.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

This is in contrast to clinical practice, where the focus is usually on measuring intermediate physiological indicators.

A

Outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

(T/F): It is usually straightforward to decide on the final outcome measure for acute conditions, as interventions are usually prevalent.

A

F / Prevalent / CURATIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

(T/F): For chronic conditions, the use of intermediate indicators is more curative.

A

F / Curative / PREVALENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

(T/F): The choice of an outcome defines the type of the economic evaluation that may be employed.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Three (3) Relative Treatment Effect

A
  1. Physiological Measures and Clinical Events
  2. Survival
  3. Quality of Life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

These are disease-specific outcome measures.

A

Physiological Measures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

It convey precise information about an individual’s bodily function.

A

Physiological Measures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give example/s of physiological measures that can be measured bodily function, and are quantifiable.

A

• Heart Rate
• Skin Temperature
• Cortisol Level
• Eye Tracking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

These are physical measures that are widely used in clinical practice.

A

• Cholesterol Levels
• Blood Pressure
• Bone Density

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

These are the physiology of our body that can be measured through numbers.

A

Physiological Measures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

(T/F): Low BP is known to be the risk factor for stroke.

A

F / Low BP / HIGH BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

(T/F): By the means of physiologic measures, we can predict the intermediate outcomes and might prevent the negative clinical events.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The expected value of the loss function / loss.

A

Risk Function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

It estimate the risk of clinical events as the function of the level of the physiological measure.

A

Risk Function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

(T/F): The ultimate aim of physiological measures is not only to avoid these events but to avoid their “consequences” in terms of disability or death.

A

T

24
Q

They are usually collected in Randomized Controlled Trials (RCTs).

A

Survival Data

25
Q

They are normally expressed as the proportion of patients alive at the end of the trial, the number of deaths averted, or (more commonly) the number of Life Years Saved (LYS).

A

Survival Data

26
Q

It examines time to event series.

A

Survival Data

27
Q

Evaluating interventions aimed at reducing the burden of chronic diseases.

A

Quality of Life (QoL)

28
Q

(T/F): The primary objective of QoL is to improve the patient’s quality of living via mental or physical abilities.

A

T

29
Q

Based on WHO, this is the combination of physical, mental and social wellbeing, not merely the absence of disease.

A

Health

30
Q

Measures of health-related QoL can either be __________.

A

Generic or Disease-Specific

31
Q

It focuses on dimensions of the patient QoL related to the particular condition.

A

Disease-Specific Measures

32
Q

Example/s of Disease-Specific Measures

A

• Beck Depression Inventory (BDI)
• Multiple Sclerosis QoL Inventory (MSQLI)

33
Q

These measures have the advantage of being more sensitive to the impact of particular diseases.

A

Disease-Specific Measures

34
Q

(T/F): Disease-Specific Measures cannot be used for decision-making regarding the allocation of resources across more than one condition.

A

T

35
Q

It do not focus on particular diseases but rather on the general dimensions of health such as depression, pain, mobility, etc.

A

Generic Measures

36
Q

Example/s of General Dimensions of Health

A

• Physical Health
• Emotional Health
• Mental Health
• Social Health
• Spiritual Health

37
Q

These measures are less sensitive to changes in patient disease status.

A

Generic Measures

38
Q

Common Used Versions of Generic Measures of HRQoL

A
  1. Short Form-36
  2. Nottingham Health Profile
  3. Sickness Impact Profile
  4. General Wellbeing Scale
39
Q

Another generic measure that can be used to compare outcomes across different patient groups and disease areas.

A

Utility

40
Q

Defined as the “value of person places on particular health state or health outcome.”

A

Utility

41
Q

It is generally between 0 to 1, death to life.

A

Utility

42
Q

It measures of the value that an individual gives particular health state.

A

Utility

43
Q

Two (2) Types of Off-The-Shell Questionnaires

A
  1. Descriptive System
  2. Accompanying Tariff
44
Q

It is preferred by health economists because it is based on making choices and taking risks.

A

Standard Gamble

45
Q

Standard Gamble involves Two (2) Alternatives

A
  1. Living in Full Health
  2. Immediate Death
46
Q

In this method, the respondent is offered Two (2) Alternatives: Alternative 1 is Full Health for Time and Alternative 2 is To Remain in Health State.

A

Time Trade-Off (TTO)

47
Q

Two (2) Preferred Methods for Measuring Utilities

A
  1. Standard Gamble
  2. Time Trade-Off (TTO)
48
Q

It is possible to elicit health state preferences directly using the direct __________ designed to elicit preferences.

A

Valuation Techniques

49
Q

When capturing the costs and benefits of an intervention, economic evaluations must account for differences in resource use and health gain over time.

A

Time Horizon

50
Q

This is the longevity of the treatment.

A

Time Horizon

51
Q

The “length of time over which costs and consequences are assessed.”

A

Time Horizon

52
Q

(T/F): If the chosen time horizon does not reflect the observed pattern of costs and consequences, then the results of an economic evaluation are likely to be reliable.

A

F / Reliable / UNRELIABLE

53
Q

Making future costs and consequences reflect their current value in this way ensures that studies reflect “positive time preference.”

A

Discounting

54
Q

This refers to our preference as individuals to consume benefits now but pay for them later.

A

Discounting

55
Q

In most studies, the “discount rate” is usually set between __________.

A

0% and 6%